Volitionrx (VNRX) Share-based Compensation Growth (3y) (2014 - 2025)
Volitionrx (VNRX) Share-based Compensation Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | - |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - | -18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.92% |
| Jun 30, 2025 | -34.54% |
| Mar 31, 2025 | -20.99% |
| Dec 31, 2024 | -33.11% |
| Sep 30, 2024 | -25.05% |
| Jun 30, 2024 | -14.91% |
| Mar 31, 2024 | -82.33% |
| Dec 31, 2023 | 29.18% |
| Sep 30, 2023 | 7.86% |
| Jun 30, 2023 | 15.15% |
| Mar 31, 2023 | 61.24% |
| Dec 31, 2022 | 26.61% |
| Sep 30, 2022 | 171.38% |
| Jun 30, 2022 | 220.15% |
| Mar 31, 2022 | 654.90% |
| Dec 31, 2021 | -26.42% |
| Sep 30, 2021 | 5.85% |
| Jun 30, 2021 | -11.85% |
| Mar 31, 2021 | -14.71% |
| Dec 31, 2020 | -49.00% |